UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000022008
Receipt No. R000025358
Scientific Title (C-SHOT1601)Phase II study of bortezomib plus Lenalidomide and dexamethasone (Once weekly BLd) for elderly or transplant-ineligible patients with untreated symptomatic multiple myeloma
Date of disclosure of the study information 2016/04/20
Last modified on 2020/10/26 10:09:46

No. Disposal Last modified on Item of update
1 Insert 2016/04/20 23:31:18
2 Update 2016/04/20 23:44:39 Institutions
3 Update 2016/04/20 23:46:29 Institutions
4 Update 2016/05/09 21:19:31 UMIN ID1
5 Update 2016/05/09 21:21:31 Email
6 Update 2017/10/23 13:11:05 Last name of contact person
Email
7 Update 2017/10/23 13:12:55 Recruitment status
Last follow-up date
8 Update 2019/10/23 11:51:35 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
9 Update 2019/10/23 11:53:05 Number of participants that the trial has enrolled
10 Update 2019/10/23 11:55:15 Date of IRB
11 Update 2020/04/23 09:22:31 Last follow-up date
12 Update 2020/10/26 10:09:46 Date of closure to data entry
Date trial data considered complete
Date analysis concluded


Contact us.